Knockdown of endothelial NOS by lentivirus-mediated short hairpin RNA in hemangioendothelioma cells increases proliferation and tumor formation.
Endothelial nitric oxide synthase (ecNOS) derived nitric oxide (NO) is a key contributor to the angiogenic process. By augmenting angiogenesis NO could potentially promote tumor progression. The object of this study was to determine how knockdown of ecNOS affects endothelial NO production and the angiogenic response in endothelial cells. EOMA cells derived from a spontaneously arising murine hemangioendothelioma were genetically manipulated to stably express siRNA targeting ecNOS. Knockdown of ecNOS in different stably transfected EOMA cell lines was demonstrated by quantitative RT-PCR, Western blot and ecNOS specific ELISA. An EOMA cell line with near complete knockdown of ecNOS exhibited dramatically altered morphology and changes in the expression of mRNAs encoding proteins involved in angiogenesis. This cell line exhibited a 4-fold increase in proliferation in vitro, altered tube formation in matrigel and formed tumors in mice more rapidly than the parental cells. In contrast, a cell line in which ecNOS protein levels were reduced only 5-fold did not show changes in proliferation rate, tube formation or tumor growth. These results suggest that ecNOS derived nitric oxide reduces the growth of hemangioendothelioma derived tumors, and underscore the importance of careful consideration of the tumor type when selecting modulation of nitric oxide signaling as a treatment strategy.
Chen
Zhi
Z
BioMarin Pharmaceuticals, Novato, CA 94949, USA.
Joshi
Sarasijam
S
Kauser
Katalin
K
Brooks
Alan R
AR
D000818:Animals; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002478:Cells, Cultured; D015536:Down-Regulation; D004730:Endothelium, Vascular / Q000737:chemistry / Q000201:enzymology*; D005786:Gene Expression Regulation; D005822:Genetic Vectors / Q000235:genetics; D006390:Hemangioendothelioma / Q000737:chemistry / Q000201:enzymology* / Q000473:pathology; D016086:Lentivirus / Q000235:genetics; D051379:Mice; D009368:Neoplasm Transplantation; D052250:Nitric Oxide Synthase Type III / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis; D034741:RNA, Small Interfering / Q000096:biosynthesis* / Q000235:genetics
D012333:RNA, Messenger; D034741:RNA, Small Interfering; D052250:Nitric Oxide Synthase Type III